PharmiWeb.com - Global Pharma News & Resources
19-Dec-2023

IV Fluid Transfer Drug Devices Industry Sets its Sights on a Projected Valuation of US$9,250.9 Million by 2033-FMI Projection

IV Fluid Transfer Drug Devices Industry

The global IV fluid transfer medication devices industry size is expected to reach US$ 9,250.9 million in value by 2033. Manufacturers of IV fluid transfer medication devices forecast a 3.4% compound annual growth rate (CAGR) for the market through 2033. The market valuation is projected to reach US$ 6,652.7 million in 2023.

The closed system of the device prevents the environmental contamination during the IV drug administration and the airtight system reduces the risk of surface contamination. The system is completely sealed at each point of connection to prevent the contamination. The IV fluid transfer drugs devices comprise a needle for the device-to-device interface. The IV fluid transfer drugs devices are the evolution in patient care which is easy to operate and integrate into practice and also helps to reduce the medication errors.

Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-6454

IV Fluid Transfer Drugs Devices Market: Drivers and Restrains

The global IV fluid transfer drugs devices are anticipated to register a significant CAGR over a forecast period. Rising threat of contamination is the primary factor for the growth of IV fluid transfer drugs devices market. Besides that increasing adoption of IV fluid transfer drugs devices during the drug administration will also propel the growth of the global market of IV fluid transfer drugs devices.

The pre-identified risk factors can upsurge the market of the IV fluid transfer drugs devices. The lack of knowledge and the lack of awareness of using these products can hamper the growth of the IV fluid transfer drugs devices market.

IV Fluid Transfer Drugs Devices Market: Overview

The increasing investment by the government is the major role for better healthcare is expected to drive the market. The companies are engrossed in introducing the products for IV fluid transfer drugs devices. The IV fluid transfer drugs devices market is classified by application and end user. In terms of product type, the global market of IV fluid transfer drugs devices is divided into autoimmune diseases, Blood Disorders, Cardiovascular, Neurology, Oncology and others.

By end user, the IV fluid transfer drugs devices market is segmented as hospitals, specialized clinics and other healthcare facilities. Among all end users, hospitals segment is expected to gain maximum value share over the forecast period.

Unlock exclusive insights with our expert analysts:
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-6454

IV Fluid Transfer Drugs Devices Market: Regional overview

On the basis of geography, IV fluid transfer drugs devices market is segmented as North America, Latin America, Western Europe, Eastern Europe, Japan, Asia-Pacific and Middle East & Africa. North America is expected to dominate the IV fluid transfer drugs devices market due to the advent of awareness and better healthcare facilities in this region.

Europe is also contributing the moderate shares to the market due to the advanced medical facilities and easy availability of the IV fluid transfer drugs devices in the market. APAC is the most lucrative market for the IV fluid transfer drugs devices due to increasing trend of being slim and toned and developing medical industry in the region is expected to show a robust growth to the global IV fluid transfer drugs devices market.

MEA is at a nascent stage to the global combat dressing market and anticipated to register a decent growth to the market over a forecast period. Overall, the global IV fluid transfer drugs devices market is expected to show significant growth over a forecast period.

IV Fluid Transfer Drugs Devices Market: Key Players

Some of the major players in the market are Advance Medical Designs, Inc., B. Braun Medical, Baxter Healthcare, 8 ICU Medical, Inc., Hospira, Q.I. Medical, Inc. and others. The IV fluid transfer drugs devices market is currently witnessing a number of strategic collaboration and partnership activities by manufacturers and distribution channel.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Unlock Tailored Insights: Customize Your Report for Maximum Impact:
https://www.futuremarketinsights.com/customization-available/rep-gb-6454

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Editor Details

Last Updated: 19-Dec-2023